NCT04051216 is a NA clinical trial of Education information system in Leukemia, Acute, sponsored by University of Michigan Rogel Cancer Center.

Who is sponsoring NCT04051216?

NCT04051216 is sponsored by University of Michigan Rogel Cancer Center.

What drugs are being tested in NCT04051216?

Interventions in NCT04051216: Education information system, Activity monitor, Interview, Survey Administration, Laboratory Biomarker Analysis.

What condition does NCT04051216 study?

NCT04051216 studies Leukemia, Acute, Leukemia, Lymphoblastic.

Is NCT04051216 still recruiting?

NCT04051216 is currently completed. Last updated 22 March 2024.

Last reviewed 2024-03-22 · How we verify

NCT04051216

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The SMART CART Study: Health Information Technology

Completed NA Last updated 22 March 2024

What this trial tests

NA trial testing Education information system in Leukemia, Acute in 148 participants. Completed in 23 November 2023.

Timeline

20 December 2017

Primary endpoint
25 August 2023

23 November 2023

Quick facts

Lead sponsor	University of Michigan Rogel Cancer Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	148
Start date	20 December 2017
Primary completion	25 August 2023
Estimated completion	23 November 2023
Sites	1 location across United States

Drugs / interventions tested

Education information system
Activity monitor
Interview
Survey Administration
Laboratory Biomarker Analysis — full drug profile →

Conditions studied

Leukemia, Acute — all drugs for Leukemia, Acute →
Leukemia, Lymphoblastic — all drugs for Leukemia, Lymphoblastic →

Sponsor

University of Michigan Rogel Cancer Center

Who can join

3 and older, any sex, with Leukemia, Acute or Leukemia, Lymphoblastic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the feasibility of using two information technology tools in patients undergoing Chimeric Antigen Receptor T-cell (CART) therapy and other Cytokine Release Syndrome (CRS)-eliciting treatments such as CD123 BITE. The first is an Apple iPad® application called the BMT Roadmap, which shows information about the participant's health. The second is a wearable activity monitoring device. Health information technology tools such as Roadmap system and the activity monitoring device may enable caregivers and patients to become more active participants in their healthcare.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Monitoring Health Care Workers at Risk for COVID-19 Using Wearable Sensors and Smartphone Technology: Protocol for an Observational mHealth Study.
Clingan CA, Dittakavi M, Rozwadowski M, Gilley KN, et al · · 2021 · cited 6× · PMID 33945497 · DOI 10.2196/29562

Verify or expand the search:

Other recruiting trials for Leukemia, Acute

Currently open trials in the same condition.

NCT04482894 — Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDS · Phase 2 · active not recruiting

Other University of Michigan Rogel Cancer Center trials

Trials by the same sponsor.

NCT06914479 — Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and · Phase 1 · recruiting
NCT07481344 — SunBeast: Evaluating UV Protective Behaviors and Education Interventions Among Ultrarunners · NA · not yet recruiting
NCT07526545 — Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial · NA · not yet recruiting
NCT07443943 — A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive · Phase 2 · recruiting
NCT07365007 — A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Ca · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04051216 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Michigan Rogel Cancer Center
Last refreshed: 22 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04051216.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing